Xiangyang No.1 People's Hospital
🇨🇳China
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
Phase 1
Not yet recruiting
- Conditions
- NK CellB-cell Lymphoma RefractoryB-cell Lymphoma Recurrent
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Xiangyang No.1 People's Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT05909098
- Locations
- 🇨🇳
EC of Xiangyang No.1 People's Hospital Hubei University of Medicine, Hubei, Xiangyang, China
News
No news found